Literature DB >> 8019289

Tacrine and lecithin in Alzheimer's disease. Serum tacrine concentrations too low.

C Roberts, P Mäkelä, J Ford, C Truman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8019289      PMCID： PMC2540320     

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

1.  Tetrahydroaminoacridine and Alzheimer's disease.

Authors:  E J Byrne; T Arie
Journal:  BMJ       Date:  1994-04-02

2.  Efficacy of tacrine and lecithin in mild to moderate Alzheimer's disease: double blind trial.

Authors:  N Maltby; G A Broe; H Creasey; A F Jorm; H Christensen; W S Brooks
Journal:  BMJ       Date:  1994-04-02

3.  An evaluation of the efficacy and safety of tetrahydroaminoacridine (THA) without lecithin in the treatment of Alzheimer's disease.

Authors:  G K Wilcock; D J Surmon; M Scott; M Boyle; K Mulligan; K A Neubauer; D O'Neill; V H Royston
Journal:  Age Ageing       Date:  1993-09       Impact factor: 10.668

4.  Serum concentrations of tacrine hydrochloride predict its adverse effects in Alzheimer's disease.

Authors:  J M Ford; C A Truman; G K Wilcock; C J Roberts
Journal:  Clin Pharmacol Ther       Date:  1993-06       Impact factor: 6.875
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.